AAAAAA

   
Results: 1-9 |
Results: 9
CONTROVERSIES IN THE TREATMENT OF PARKINSONS-DISEASE
Authors: HELY MA MORRIS JGL
Citation: Ma. Hely et Jgl. Morris, CONTROVERSIES IN THE TREATMENT OF PARKINSONS-DISEASE, Current opinion in neurology, 9(4), 1996, pp. 308-313
REGIONAL BRAIN ATROPHY IN IDIOPATHIC PARKINSONS-DISEASE AND DIFFUSE LEWY BODY DISEASE
Authors: DOUBLE KL HALLIDAY GM MCRITCHIE DA REID WGJ HELY MA MORRIS JGL
Citation: Kl. Double et al., REGIONAL BRAIN ATROPHY IN IDIOPATHIC PARKINSONS-DISEASE AND DIFFUSE LEWY BODY DISEASE, Dementia, 7(6), 1996, pp. 304-313
A LONGITUDINAL-STUDY OF PARKINSONS-DISEASE - CLINICAL AND NEUROPSYCHOLOGICAL CORRELATES OF DEMENTIA
Authors: REID WGJ HELY MA MORRIS JGL BROE GA ADENA M SULLIVAN DJO WILLIAMSON PM
Citation: Wgj. Reid et al., A LONGITUDINAL-STUDY OF PARKINSONS-DISEASE - CLINICAL AND NEUROPSYCHOLOGICAL CORRELATES OF DEMENTIA, Journal of clinical neuroscience, 3(4), 1996, pp. 327-333
AN AUSTRALIAN MULTICENTER OPEN-LABEL STUDY OF PERGOLIDE AS AN ADJUNCTTO LEVODOPA IN PARKINSONS-DISEASE
Authors: HELY MA MORRIS JGL BURNS RJ LANDER CM MCLAUGHLIN DB DONNAN GA
Citation: Ma. Hely et al., AN AUSTRALIAN MULTICENTER OPEN-LABEL STUDY OF PERGOLIDE AS AN ADJUNCTTO LEVODOPA IN PARKINSONS-DISEASE, Journal of clinical neuroscience, 3(3), 1996, pp. 234-238
MIDBRAIN NEUROPATHOLOGY IN IDIOPATHIC PARKINSONS-DISEASE AND DIFFUSE LEWY BODY DISEASE
Authors: HALLIDAY GM MCRITCHIE DA CARTWRIGHT H PAMPHLETT R HELY MA MORRIS JGL
Citation: Gm. Halliday et al., MIDBRAIN NEUROPATHOLOGY IN IDIOPATHIC PARKINSONS-DISEASE AND DIFFUSE LEWY BODY DISEASE, Journal of clinical neuroscience, 3(1), 1996, pp. 52-60
DIFFUSE LEWY BODY DISEASE - CLINICAL-FEATURES IN 9 CASES WITHOUT COEXISTENT ALZHEIMERS-DISEASE
Authors: HELY MA REID WGJ HALLIDAY GM MCRITCHIE DA LEICESTER J JOFFE R BROOKS W BROE GA MORRIS JGL
Citation: Ma. Hely et al., DIFFUSE LEWY BODY DISEASE - CLINICAL-FEATURES IN 9 CASES WITHOUT COEXISTENT ALZHEIMERS-DISEASE, Journal of Neurology, Neurosurgery and Psychiatry, 60(5), 1996, pp. 531-538
AGE AT ONSET - THE MAJOR DETERMINANT OF OUTCOME IN PARKINSONS-DISEASE
Authors: HELY MA MORRIS JGL REID WGJ OSULLIVAN DJ WILLIAMSON PM BROE GA
Citation: Ma. Hely et al., AGE AT ONSET - THE MAJOR DETERMINANT OF OUTCOME IN PARKINSONS-DISEASE, Acta neurologica Scandinavica, 92(6), 1995, pp. 455-463
THE SYDNEY MULTICENTER STUDY OF PARKINSONS-DISEASE - A RANDOMIZED, PROSPECTIVE 5-YEAR STUDY COMPARING LOW-DOSE BROMOCRIPTINE WITH LOW-DOSE LEVODOPA-CARBIDOPA
Authors: HELY MA MORRIS JGL REID WGJ OSULLIVAN DJ WILLIAMSON PM RAIL D BROE GA MARGRIE S
Citation: Ma. Hely et al., THE SYDNEY MULTICENTER STUDY OF PARKINSONS-DISEASE - A RANDOMIZED, PROSPECTIVE 5-YEAR STUDY COMPARING LOW-DOSE BROMOCRIPTINE WITH LOW-DOSE LEVODOPA-CARBIDOPA, Journal of Neurology, Neurosurgery and Psychiatry, 57(8), 1994, pp. 903-910
RELIABILITY OF THE COLUMBIA SCALE FOR ASSESSING SIGNS OF PARKINSONS-DISEASE
Authors: HELY MA CHEY T WILSON A WILLIAMSON PM OSULLIVAN DJ RAIL D MORRIS JGL
Citation: Ma. Hely et al., RELIABILITY OF THE COLUMBIA SCALE FOR ASSESSING SIGNS OF PARKINSONS-DISEASE, Movement disorders, 8(4), 1993, pp. 466-472
Risultati: 1-9 |